Literature DB >> 7543713

Effect of low-dose subcutaneous heparin on postoperative wound hematomas: randomized clinical trial on hospitalized inguinal hernia patients in Germany.

R Schmitz1, M Kansy, K H Moser, J Treckmann.   

Abstract

A randomized prospective study of low-dose heparin was performed in 89 surgical patients during and after Bassini-Lotheissen repair. The patients were divided into two groups: (1) Low-dose heparin: 5000 units 2 hours before operation and 5000 units every 8 hours for 5 days after the operation. (2) Dextran 40 (Rheomacrodex); administered during the operation, with an additional infusion of dextran (500 ml/day) for the next 3 days. The frequency of wound complications in 45 the heparin-treated patients was 22.0% (comprising 10 hematomas), compared to only 4.5% in the dextran-treated patients (n = 44 patients). These findings are significant (p < 0.05). Low-dose heparin should therefore be administered routinely only to patients with increased risk of thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543713     DOI: 10.1007/bf00299176

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  11 in total

Review 1.  The antithrombotic efficacy of dextran.

Authors:  K G Ljungström
Journal:  Acta Chir Scand Suppl       Date:  1988

2.  Subcutaneous heparin and postoperative wound hematomas. A prospective, double-blind, randomized study.

Authors:  B van Ooijen
Journal:  Arch Surg       Date:  1986-08

3.  Low-dose heparin prophylaxis in herniorrhaphy? A prospective trial in bleeding complications.

Authors:  M Dommering
Journal:  Arch Chir Neerl       Date:  1979

4.  Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial.

Authors:  V V Kakkar; T Corrigan; J Spindler; D P Fossard; P T Flute; R Q Crellin; S Wessler; E T Yin
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

5.  Low doses of heparin in prevention of deep-vein thrombosis.

Authors:  V V Kakkar; E S Field; A N Nicolaides; P T Flute
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

6.  [Complications following inguinal hernia surgery].

Authors:  E Ungeheuer; F Herrmann
Journal:  Chirurg       Date:  1984-09       Impact factor: 0.955

7.  Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran.

Authors:  D Oertli; P Hess; M Durig; U Laffer; R Fridrich; K Jaeger; R Kaufmann; F Harder
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

8.  Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.

Authors: 
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

9.  Low dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study.

Authors:  H L Pachter; T S Riles
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

10.  Ultra-low dose intravenous heparin in the prevention of postoperative deep-vein thrombosis.

Authors:  D Negus; A Friedgood; S J Cox; A L Peel; B W Wells
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

View more
  3 in total

1.  Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy.

Authors:  M Hauer-Jensen; C Fort; J L Mehta; L M Fink
Journal:  Hernia       Date:  2005-09-08       Impact factor: 4.739

2.  Postoperative hematoma following inguinal herniorrhaphy: patient characteristics leading to increased risk.

Authors:  R L Smoot; G S Oderich; C B Taner; S M Greenlee; D R Larson; E B Cragun; D R Farley
Journal:  Hernia       Date:  2007-12-04       Impact factor: 4.739

3.  International guidelines for groin hernia management.

Authors: 
Journal:  Hernia       Date:  2018-01-12       Impact factor: 4.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.